Showing results (521-530 of 536) with videos related to
Sort By:
Pageof 54
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.Plos One|April 3, 2023
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanomaIrene Orlow, Keimya D Sadeghi, Sharon N Edmiston, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III MelanomaJennifer M Wiggins, Qiao Zhang, Yian Zhang, et al.Nature Genetics|October 11, 2011
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3Stuart Macgregor, Grant W Montgomery, Jimmy Z Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic MelanomaAndrew W Hahn, Ashley V Menk, Dayana B Rivadeneira, et al.NPJ Genomic Medicine|August 19, 2017
Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.Nature|January 17, 2020
B cells and tertiary lymphoid structures promote immunotherapy responseBeth A Helmink, Sangeetha M Reddy, Jianjun Gao, et al.Journal of the National Cancer Institute|September 19, 2014
The effect on melanoma risk of genes previously associated with telomere lengthMark M Iles, D Timothy Bishop, John C Taylor, et al.Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.Nature Genetics|May 8, 2012
Detectable clonal mosaicism from birth to old age and its relationship to cancerCathy C Laurie, Cecelia A Laurie, Kenneth Rice, et al.Pageof 54